The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback